FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/18/2024
Back to search
Official data from USPTO
SEONIX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
SEONIX
ST13
US500000079343123Class
5, 9, 44
Filing
79343123
Registration
7220507
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
03/18/2024
Classification
Registered
Trademark type
Word
Nice classes
5, 9, 44
Filing date
04/08/2022
Registration date
11/21/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/21/2023
Last transaction
11/21/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
AU
Examiner
BLAKESLEE, RICHARD A
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Seonix Pty Ltd
Representatives
Max Vern Amster, Rothstein & Ebenstein LLP
Technical classification
Nice Classes
Class 5Class 9Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Reagents for medical or clinical testing in the nature of medical diagnostic reagents and assays for testing of bodily fluids; reagents for use in medical genetic testing; bloodbuccal and saliva swabs and preserving reagents for collecting DNA samples for medical or clinical testing; reagents for use in diagnostic testing for medical purposes; diagnostic kits comprised primarily of test reagents for use in medical testing; diagnostic kits comprised primarily of test reagents for use in medical genetic testing
Class 9
Downloadable computer software for analysingreportingscreening and tracking data and information for use in the fields of healthmedicinepharmaceutical developmentgeneticsbioinformaticsophthalmologyeye health; downloadable computer software for collectinganalysingreportingscreening and tracking data and information in the fields of healthmedicinepharmaceutical developmentgeneticsbioinformaticsophthalmologyeye health; downloadable computer software for providing medical or health evaluations; downloadable computer software for providing disease assessment and treatment; downloadable computer software for providing medical or health assessment; downloadable computer software for evaluation and health recommendations based on geneticgenomicimagingclinical data; downloadable computer software for ophthalmological testing or screening; downloadable computer software for glaucoma testing or screening
Class 44
Medical testing and medical clinical diagnosticsmedical and diagnostic testing services for risk assessmentscreeningdiagnosis and treatment of disease; ophthalmological testing; genetic testing and screening for medical purposes; medical testingscreening and analysis services utilising an on-line portal; medical testingscreening and analysis services utilising input of genetic and clinical data via an on-line portal or paper referral; medical genetic analysis servicesin particulargenome mappinggenome analysisgenome scanning; medical genetic diagnostic testingscreening and reporting services; medical diagnostic testingscreening and reporting services; medical testing servicesmedical testing and reporting services relating to the screeningdiagnosis and treatment of disease; medical health advisory services; eye health advisory services; medical health assessment services; advisory services relating to eye health; eye health screening; glaucoma testing and screening
Publications
History of USPTO decisions and trademark events.
25 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/22/2024
FIMP
FINAL DISPOSITION PROCESSED
02/22/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/21/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/21/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/21/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/05/2023
PUBO
PUBLISHED FOR OPPOSITION
09/05/2023
GPNX
NOTIFICATION PROCESSED BY IB
09/04/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/16/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/16/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/16/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/28/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/24/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/23/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/23/2023
RFNT
REFUSAL PROCESSED BY IB
04/13/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/23/2023
RFRR
REFUSAL PROCESSED BY MPU
03/23/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/28/2023
CNRT
NON-FINAL ACTION WRITTEN
01/27/2023
DOCK
ASSIGNED TO EXAMINER
01/26/2023
MAFR
APPLICATION FILING RECEIPT MAILED
06/28/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/24/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/23/2022
Continuous trademark protection
Get notified about every new filing that threatens SEONIX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.